National Comprehensive Cancer Network



About NCCN

Soft Tissue Sarcoma Panel - Disclosures as of 4/24/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Robert S. Benjamin, MD

None

None

Johnson & Johnson;
Merck & Co., Inc.;
Pfizer Inc.

None

8/21/2013

Mary Anne Bergman

None

None

None

None

10/7/2013

Sarah Boles, MD

None

None

None

None

6/19/2013

Marilyn M. Bui, MD, PhD

None

None

None

None

12/21/2013

Ernest U. Conrad III, MD

None

None

None

None

3/21/2012

Thomas F. DeLaney, MD

None

Chordoma Foundation;
Evidence for Healthcare Improvement;
Group H;
Monitor Deloitte Consulting;
The Planning Shop

GlaxoSmithKline

None

3/27/2014

Fayna Ferkle, PharmD

None

None

None

None

3/26/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Kristen N. Ganjoo, MD

None

None

None

None

8/17/2012

Suzanne George, MD

Bayer HealthCare;
Eisai Inc.;
Johnson & Johnson;
Novartis Pharmaceuticals Corporation

Bayer HealthCare;
GlaxoSmithKline;
Pfizer Inc.

None

None

5/27/2013

Ricardo J. Gonzalez, MD

None

Novartis Pharmaceuticals Corporation

None

None

1/27/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Martin J. Heslin, MD

None

None

None

None

1/26/2014

John M. Kane III, MD

None

None

None

None

9/24/2013

Joel Mayerson, MD

Millennium Pharmaceuticals, Inc.

None

None

None

4/30/2013

Martin McCarter, MD

None

None

None

None

8/23/2013

Joan S. McClure, MS

None

None

None

None

8/13/2013

Sean V. McGarry, MD

None

None

None

Musculoskeletal Transplant Foundation

8/23/2013

Nicole McMillian, MS

None

None

None

None

3/9/2014

Christian Meyer, MD, PhD

None

None

None

None

9/11/2012

Richard J. O'Donnell, MD

None

None

None

None

3/27/2013

Alberto S. Pappo, MD

None

None

None

None

7/29/2013

I. Benjamin Paz, MD

Agendia BV

Genomic Health, Inc.

None

None

1/24/2014

John D. Pfeifer, MD, PhD

None

None

None

None

6/4/2013

R. Lor Randall, MD, FACS

Children`s Oncology Group;
Connective tissue Oncology Society;
Musculoskeletal Tumor Society

Biomet;
Musculoskeletal Transplant Foundation;
Musculoskeletal Transplant Foundation

None

Biomet

3/31/2014

Richard F. Riedel, MD

Eisai Inc.;
GlaxoSmithKline;
Millennium Pharmaceuticals, Inc.;
Morphotek Inc.;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
ASTEX;
CytRx Corporation;
Infinity Pharmaceuticals;
Threshold;
Threshold;
Tracon;
Ziopharm

Novartis Pharmaceuticals Corporation;
EMD Serono

None

Morphotek Inc.;
CytRx

3/21/2014

Jillian Scavone

None

None

None

None

3/4/2014

Scott Schuetze, MD, PhD

Amgen Inc.;
Johnson & Johnson;
Novartis Pharmaceuticals Corporation;
AB Sciences;
SARC;
Threshold

Amgen Inc.;
Novartis Pharmaceuticals Corporation;
Sarcoma Alliance for Research through Collaboration

None

None

1/24/2014

Karen D. Schupak, MD

None

None

None

None

1/31/2014

Herbert S. Schwartz, MD

None

None

None

Musculoskeletal Transplant Foundation;
Musculoskeletal Transplant Foundation

1/25/2014

William D. Tap, MD

ImClone Systems Incorporated;
Morphotek Inc.;
Threshold Pharmaceuticals

Novartis Pharmaceuticals Corporation;
Plexxikon Pharmaceuticals

None

None

12/5/2013

Margaret von Mehren, MD

Eisai Inc.;
GlaxoSmithKline;
Johnson & Johnson;
Merck & Co., Inc.;
Morphotek Inc.;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
OSI Pharmaceuticals, Inc.;
Arog Pharmaceuticals;
Astex;
Infinity;
Pharma Mar;
Sarcoma Alliance for Research through Collaboration;
Pfizer Inc.;
Synta Pharmaceuticals Corp.

Eisai Inc.;
GlaxoSmithKline;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Pharma Mar;
Pfizer Inc.

None

None

8/16/2013

Jeffrey D. Wayne, MD

None

Novartis Pharmaceuticals Corporation

None

None

1/24/2014